Concall Intelligence
Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.
Management evidence
Generated 23 Oct, 1:05 am IST · click a summary to inspect source-linked evidence for this results quarter.
| Company | Call and sources | Reported result | Management outlook | Evidence-led conclusion | Review |
|---|---|---|---|---|---|
| KARURVYSYA Karur Vysya Bank Limited Financial Services · Small | Sep 2026 19 Oct 2026 Transcript verified | Excellent 75/100 | Optimistic outlook No comparable prior call Guidance maintained | Karur Vysya Bank delivered strong revenue and profit growth in Q2 FY26-27, with business expansion and robust CASA inflows, while maintaining NIM above guidance; management signals cautious but optimistic outlook for FY26-27 growth of 18-20% and highlights competitive pressure on margins. Evidence summary ready | |
| IOLCP IOL Chemicals and Pharmaceuticals Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | IOL Chemicals and Pharmaceuticals Limited reported its business update call focusing on three strategic growth initiatives totalling approximately INR500 crores, including Ibuprofen capacity expansion, entry into the CDMO formulations segment, and a specialty chemical tolling arrangement. Management highlighted disciplined internal accrual funding and long-term customer relationships, while noting that input prices have stabilized and some product prices have softened from pe Evidence summary ready | |
| TEMPSENS Tempsens Instruments (India) Limited Industrials · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Tempsens Instruments (India) Limited reported a strong Q1 FY27 with revenue growing 33% YoY to INR118 crores and export revenues rising 78.3%, while EBITDA margins moderated by 330 bps to 22% due to employee cost investments for future growth and timing of execution. Evidence summary ready | |
| METROPOLIS Metropolis Healthcare Limited Pharma · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Metropolis Healthcare reported robust strategic positioning during its Investor and Analyst Meet, highlighting strong volume-led growth across B2C and B2B channels, expansion in tier-2/tier-3 towns, and margin expansion levers driven by specialty testing, genomics, and network productivity. Evidence summary ready | |
| NOVARTIND Novartis India Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Novartis India Limited is undergoing a complete commercial reset following its acquisition by ChrysCapital. The management aims to transition the company from a flattish revenue trajectory to a high-growth platform by building an internal field force of ~900 representatives, expanding distribution to 25 C&Fs and 4,000-5,000 distributors, executing strategic M&As (such as Minipress XL and ophthalmology in-licensing), and focusing on six core therapy areas. Evidence summary ready | |
| INDOBORAX Indo Borax & Chemicals Limited Industrials · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Indo Borax reported strong Q1 FY27 results with 31% operating revenue growth and a 59% jump in net profit, supported by robust execution and improved realizations. Management remains focused on operational efficiency, capacity utilization, and executing the acquisition of a majority stake in Kronox Lab Sciences. Evidence summary ready | |
| INDIGOPNTS Indigo Paints Limited Consumer · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Indigo Paints delivered a strong Q1 FY27 with 18.7% standalone revenue growth and a 42% jump in EBITDA, outperforming the broader paint sector despite initial raw material supply disruptions triggered by the Iran conflict. Evidence summary ready | |
| SHANKESH Shankesh Jewellers Limited Consumer · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Shankesh Jewellers Limited reported its maiden Q1 FY27 earnings post listing, highlighting strong top-line and margin expansion driven by product mix and festive demand, though the steep margin trajectory and heavy reliance on short-term working capital require close monitoring. Evidence summary ready | |
| PARKHOTELS Apeejay Surrendra Park Hotels Limited Consumer · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Apeejay Surrendra Park Hotels Limited reported solid Q1 FY2027 performance with consolidated revenue up 10% YoY to Rs. 172 crores and EBITDA up 8% YoY to Rs. 52 crores, despite macroeconomic headwinds, West Asia disruptions, and subdued air traffic. Leadership in occupancy (92%) and upper upscale RevPAR was retained, while Flurys expanded to 111 outlets. Profit after tax declined 14% YoY to Rs. 12 crores due to higher finance costs for expansion and a deferred tax provision a Evidence summary ready | |
| XTGLOBAL Xtglobal Infotech Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Xtglobal Infotech reported steady operating performance for Q1 FY27 with modest revenue growth offset by a shift from onsite to offshore delivery, leading to margin expansion. Evidence summary ready | |
| FORTIS Fortis Healthcare Limited Pharma · Mid | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Management addressed investor queries following the Delhi High Court order directing a forensic audit related to historical promoter share dissipation and IHH's acquisition, maintaining that operations remain insulated and strategic growth plans are unaffected. Evidence summary ready | |
| SKYWAYS Skyways Air Services Limited Services · Micro | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Skyways Air Services Limited reported a strong first earnings call for Q1 FY27, showcasing stellar revenue and operating EBITDA growth driven by robust air and ocean cargo volumes, alongside successful navigation of geopolitical crises like the West Asia conflict. However, yield improvements are largely tied to dynamic fuel index increases which act as a complete pass-through, and certain legal overhangs remain sub judice. Evidence summary ready | |
| ASTERDM Aster DM Healthcare Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | The successful merger and strong proforma FY2026 results, coupled with clear strategic priorities for integration and network expansion, suggest the company is on track to leverage scale and clinical depth. Management's focus on capital efficiency and margin improvement supports the long-term value creation thesis. Evidence summary ready | |
| ESDS ESDS Software Solution Limited IT · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | ESDS Software Solution reported steady Q1 FY27 results with revenue of INR 133.66 crores up 7.28% YoY and PAT of INR 29.28 crores up 14% YoY, while experiencing a sequential revenue dip due to prior quarter design services. Management highlighted strategic progress in AI cloud infrastructure and significant international GPU demand backed by substantial customer advances, though execution and delivery schedules remain sensitive to global hardware supply constraints. Evidence summary ready | |
| PRASOLCHEM Prasol Chemicals Limited Chemicals · Micro | Oct 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Prasol Chemicals reported an exceptional Q1 FY27 driven by strong underlying demand, higher realizations from lower-cost inventory in a rising price environment due to geopolitical supply-chain disruptions, and improved plant utilization, particularly at the Mahad facility which has turned EBITDA and PBT positive. Evidence summary ready | |
| UCOBANK UCO Bank Financial Services · Large | Oct 2026 19 Oct 2026 Transcript verified | Good 60/100 | Optimistic outlook No comparable prior call Guidance maintained | UCO Bank posted robust growth in advances and deposits, improved asset quality and stayed within most guidance, but faces margin pressure from hardened yields and a slight dip in CASA ratio. Evidence summary ready | |
| CRAMC Canara Robeco Asset Management Company Limited Financial Services · Micro | Oct 2026 19 Oct 2026 Transcript verified | Average 47/100 | Optimistic outlook No comparable prior call New guidance | Canara Robeco Asset Management Company (CRAMC) reported strong Q2 and H1 FY27 financial performance with double-digit YoY growth in revenue and PAT, despite significant market volatility and foreign portfolio outflows. Management highlighted the resilience of domestic investor participation and steady SIP flows as key industry drivers. The company plans to expand its product offerings with new NFOs and evaluate new business lines like passives, SIF, AIF, and GIFT City, while Evidence summary ready | |
| TCS Tata Consultancy Services Limited IT · Large | Oct 2026 19 Oct 2026 Transcript verified | Average 32/100 | Optimistic outlook No comparable prior call No measurable guidance | TCS sustained growth momentum in Q2FY27, reporting 1.3% sequential revenue growth (0.5% in constant currency) and 11.2% YoY revenue growth (2.8% in constant currency). Operating margins remained stable at 24%. The company's order book was healthy at US$9.6 billion, and annualized AI revenue crossed US$3.1 billion, representing over 10% of total revenue. While management expressed confidence in medium-term growth driven by a strong pipeline and increasing AI adoption, they ack Evidence summary ready | |
| CANBK Canara Bank Financial Services · Large | Oct 2026 19 Oct 2026 Transcript verified | Average 50/100 | Optimistic outlook No comparable prior call Guidance maintained | Canara Bank delivered a strong Q2 FY27, significantly surpassing most of its annual guidance targets across business growth, advances, deposits, asset quality, and profitability. While treasury operations faced headwinds, robust Net Interest Income growth compensated for the losses. Management remains optimistic about sustaining performance and managing the anticipated one-time ECL provisioning impact over the next few years. Evidence summary ready | |
| FEDERALBNK The Federal Bank Limited Financial Services · Mid | Sept 2026 18 Oct 2026 Preliminary brief | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | The Federal Bank Limited reported strong financial performance for Q1 FY27, driven by a 36.6% YoY growth in net profit to INR 1,177 Cr, improving NIM at 3.33%, and decadal-best asset quality metrics including a Net NPA of 0.18%. Management continues to execute Project Breakthrough 4.0 with robust granular deposit mobilisation (85% granular funding share) and strong institutional backing from IFC and Blackstone. Evidence summary ready | |
| AXISBANK Axis Bank Limited Financial Services · Large | Sept 2026 17 Oct 2026 Preliminary brief | Good 70/100 | Optimistic outlook No comparable prior call No measurable guidance | Axis Bank delivered robust Q2FY27 performance with advances up 23% YoY and deposits up 21% YoY, while net profit grew 38% YoY to ₹7,003 crores supported by healthy net interest income growth and improving asset quality metrics. Evidence summary ready | |
| ICICIBANK ICICI Bank Limited Financial Services · Large | Sep 2026 17 Oct 2026 Preliminary brief | Good 70/100 | Optimistic outlook No comparable prior call No measurable guidance | ICICI Bank delivered robust performance in Q2-2027 with a 20.1% y-o-y increase in profit after tax to ₹ 148.43 bn, supported by strong loan growth across business banking and domestic corporate portfolios, further improvements in asset quality ratios, and healthy capital adequacy. Evidence summary ready | |
| URBANCO Urban Company Limited Consumer · Small | Sep 2026 17 Oct 2026 Transcript verified | Bad 22/100 | Optimistic outlook No comparable prior call Guidance maintained | Urban Company reported strong growth across its core businesses, with consolidated NTV up 39.1% YoY and revenue up 41.4% YoY. The core businesses (India Consumer Services, International, Native) are showing significant operating leverage and margin expansion, leading to a positive adjusted EBITDA of ₹30 crores excluding InstaHelp. However, consolidated results reflect a substantial ₹174 crore investment in InstaHelp, which remains a strategic focus for long-term market leader Evidence summary ready | |
| ONWARDTEC Onward Technologies Limited IT · Small | Sept 2026 17 Oct 2026 Preliminary brief | Excellent 90/100 | Optimistic outlook No comparable prior call Guidance maintained | Onward Technologies reported a strong performance for Q2 FY27 with revenue reaching 170.2Cr (up 22.4% YoY) and PAT at 16.8Cr (up 39.8% YoY), supported by operating leverage, improved utilization, and higher-value digital engineering contracts. Evidence summary ready | |
| CANFINHOME Can Fin Homes Limited Financial Services · Large | Sep 2026 17 Oct 2026 Transcript verified | Average 30/100 | Optimistic outlook No comparable prior call Guidance maintained | Can Fin Homes experienced a significant impact on Q2 FY27 disbursements due to its IT transformation project, Project Tejas, which is now fully live. Despite this, management maintains its full-year disbursement and AUM growth guidance, confident in a strong H2 recovery driven by increased sales team strength, new branches, and robust underlying demand. The company also aims to protect its NIM and spread by strategically passing on interest rate hikes. Evidence summary ready | |
| CROMPTON Crompton Greaves Consumer Electricals Limited Consumer · Small | Sept 2026 16 Oct 2026 Preliminary brief | Excellent 100/100 | Optimistic outlook No comparable prior call Guidance maintained | Crompton delivered a strong Q2 FY27 performance with consolidated revenue growing 18.2% YoY to Rs 2,263.3 Cr and PAT surging 64.9% YoY to Rs 124.4 Cr. Growth was broad-based across all segments, supported by double-digit growth in ECD, robust performance in Lighting, and continued momentum in Butterfly. However, management highlighted ongoing input cost pressures from commodity inflation and an increase in net working capital due to inventory buildup. Evidence summary ready | |
| PNB Punjab National Bank Financial Services · Large | Sept 2026 16 Oct 2026 Preliminary brief | Average 50/100 | Optimistic outlook No comparable prior call Guidance maintained | Punjab National Bank reported solid performance for Q2 FY27 with global business expanding 11.9% YoY to 31,18,434 Crore and net profit reaching 5,532 Crore, up 12.8% YoY. Asset quality metrics improved further with Gross NPA dropping to 2.55% and provision coverage ratio rising to 97.32%. While credit growth exceeded the upper bound of annual guidance, CASA share and operating profit growth lagged initial targets. Evidence summary ready | |
| BAJAJHFL Bajaj Housing Finance Limited Financial Services · Large | Sept 2026 16 Oct 2026 Preliminary brief | Good 60/100 | Optimistic outlook No comparable prior call No measurable guidance | Bajaj Housing Finance Limited reported strong financial and operational performance for Q2 FY27, marked by a 25% YoY increase in Assets Under Management to ₹ 1,58,205 crore, a 18% YoY growth in Profit After Tax to ₹ 757 crore, and stable asset quality with GNPA at 0.29%. Evidence summary ready | |
| RBLBANK RBL Bank Limited Financial Services · Small | Sept 2026 16 Oct 2026 Preliminary brief | Excellent 85/100 | Optimistic outlook No comparable prior call No measurable guidance | RBL Bank reported a strong transformation following the completion of Emirates NBD's majority acquisition, resulting in massive capital expansion, superior credit ratings, and improving asset quality metrics in Q1 FY2027. Evidence summary ready | |
| LTF L&T Finance Limited Financial Services · Mid | Sept 2026 16 Oct 2026 Preliminary brief | Good 65/100 | Optimistic outlook No comparable prior call Guidance maintained | L&T Finance Limited (LTF) delivered strong financial performance for Q2FY27, characterized by 28% YoY book growth to Rs. 1,36,635 Cr, a 33% YoY increase in PAT to Rs. 975 Cr, and an expanding RoE of 13.56%. The company continues to advance its Lakshya 2031 strategy, anchored heavily by proprietary AI and deep tech platforms like Cyclops and Nostradamus, while maintaining robust asset quality and stable liability costs. Evidence summary ready | |
| GROWW Billionbrains Garage Ventures Limited Financial Services · Mid | Sept 2026 16 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Billionbrains Garage Ventures Limited (Groww) reported Q2 FY27 earnings with flat operational performance, impacted by higher cost-to-serve from one-time expiry file delays, AI infrastructure spending, and active trading days, alongside a seasonal drop in cost-to-grow due to the absence of IPL branding expenses. Evidence summary ready | |
| WIPRO Wipro Limited IT · Large | Sept 2026 16 Oct 2026 Transcript verified | Bad 5/100 | Cautious outlook No comparable prior call No measurable guidance | Wipro delivered flat‑sequential revenue with modest margin expansion, highlighted growing AI‑related wins and sector‑specific momentum, but flagged a soft demand backdrop, US healthcare policy headwinds and seasonal furloughs that constrain Q3 outlook. Evidence summary ready | |
| SWSOLAR Sterling and Wilson Renewable Energy Limited Infra · Micro | Sep 2026 16 Oct 2026 Preliminary brief | Bad 0/100 | Optimistic outlook No comparable prior call No measurable guidance | Sterling and Wilson Renewable Energy Limited reported a decline in overall revenue and profitability for Q2 FY27 due to lower execution in the International EPC segment, although O&M revenue saw strong growth and gross margins showed slight improvement. Evidence summary ready | |
| ANANDRATHI Anand Rathi Wealth Limited Financial Services · Small | Sep 2026 16 Oct 2026 Transcript verified | Bad 2/100 | Optimistic outlook No comparable prior call Guidance maintained | Anand Rathi Wealth delivered a strong Q2 and H1 FY27, reporting consistent year-on-year growth in PAT and revenue, despite a challenging market environment. The company achieved record net flows and client acquisitions, maintaining low attrition rates. Management expressed optimism about future growth, reaffirming full-year guidance for revenue and PAT, and outlined strategic initiatives including the upcoming mutual fund license application and operationalization of GIFT Cit Evidence summary ready | |
| HCLTECH HCL Technologies Limited IT · Large | Sept 2026 15 Oct 2026 Transcript verified | Good 70/100 | Cautious outlook No comparable prior call Guidance maintained | HCLTech delivered solid top‑line growth and margin expansion, driven by strong Advanced AI services and record bookings, while software revenue declined and margin guidance remains cautious. Evidence summary ready | |
| HDFCLIFE HDFC Life Insurance Company Limited Financial Services · Large | Sept 2026 15 Oct 2026 Preliminary brief | Average 35/100 | Optimistic outlook No comparable prior call Guidance maintained | HDFC Life delivered a resilient performance for H1 FY27, reporting steady growth in APE, Value of New Business (VNB), and Profit After Tax, supported by strong retail protection growth and a well-diversified distribution and product mix. Evidence summary ready | |
| POONAWALLA Poonawalla Fincorp Limited Financial Services · Small | Sep 2026 14 Oct 2026 Transcript verified | Excellent 85/100 | Optimistic outlook No comparable prior call Guidance maintained | Poonawalla Fincorp reported a strong quarter, marking an 'inflection point' with significant improvements across key financial metrics. The company achieved disciplined AUM expansion, enhanced NIM and fee income, and reduced credit costs, leading to a structural lift in ROA. New product launches are scaling well, contributing significantly to disbursements, and the cross-sell engine is beginning to fire. Asset quality metrics showed broad-based improvement, supported by robus Evidence summary ready | |
| KANOHAR Kanohar Electricals Limited Industrials · Micro | Sept 2026 14 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Kanohar Electricals reported a strong operational and financial performance for Q1 FY27, driven by robust volume growth in 400 kV power transformers and specialized railway transformers, backed by healthy order inflows and stable margin profiles supported by price variation clauses. Evidence summary ready | |
| SUDARSCHEM Sudarshan Chemical Industries Limited Chemicals · Micro | Sep 2026 10 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Sudarshan Chemical delivered a robust Q1 FY2027 performance following the Clariant-Heubach integration, achieving consolidated revenue of over Rs.2,600 Crores and solid EBITDA expansion. Despite geopolitical headwinds and supply chain friction, management remains focused on value capture, cost reduction, and completing IT integration while maintaining a cautious wait-and-watch approach on guidance. Evidence summary ready | |
| KMEW Knowledge Marine & Engineering Works Limited Industrials · Small | Sep 2026 10 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance raised | Knowledge Marine & Engineering Works Limited reported robust financial growth for Q1 FY27, driven by strong execution in core dredging and specialized asset deployment. Management remains confident in scaling operations across dredging, chartering, and shipbuilding, targeting a INR1,000 crores top-line by FY29. Evidence summary ready | |
| STLTECH Sterlite Technologies Limited Telecom · Micro | Sep 2026 10 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call New guidance | Sterlite Technologies Limited held an investor and analyst meeting on September 3, 2026, announcing its strategic growth roadmap titled 'Lakshya' targeting INR 20,000 crore revenue and over 27% EBITDA margin by FY29. The management highlighted the structural shift from connecting people via traditional telecom to connecting intelligence and compute inside AI data centers, supported by an open order book of over $2 billion and planned annual capital expenditure of approximatel Evidence summary ready | |
| CENTUM Centum Electronics Limited Industrials · Small | Sep 2026 10 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Centum Electronics delivered a steady Q1 FY27 performance with stand-alone revenue growing 11% YoY to INR205 crores and stand-alone order book expanding 31% YoY to INR1,800 crores. The quarter was marked by the successful completion and deconsolidation of overseas subsidiaries, eliminating future liabilities and sharpening focus on the core India ESDM platform, despite some near-term margin mutedness due to project phasing in the BTS segment. Evidence summary ready | |
| INDIAGLYCO India Glycols Limited FMCG · Micro | Sep 2026 10 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | India Glycols delivered a strong Q1 FY27 with double-digit growth in gross revenue, EBITDA, and PAT, alongside steady progress on its NCLT-approved business restructuring into separate entities. Evidence summary ready | |
| BANSALWIRE Bansal Wire Industries Limited Industrials · Small | Sep 2026 10 Oct 2026 Transcript verified | Excellent 90/100 | Optimistic outlook No comparable prior call Guidance raised | Bansal Wire Industries Limited reported a strong financial year for FY2025-26 with consolidated revenue growing 19% to Rs 4,160 crore, EBITDA up 17% to Rs 324 crore, and PAT rising 10% to Rs 161 crore, backed by record volumes of 4,58,000 tonnes. Management remains optimistic about sustainable growth driven by capacity expansion at Dadri, scaling of high-margin specialty and B2C segments, and improved cash generation. Evidence summary ready | |
| MANINDS Man Industries (India) Limited Industrials · Small | Sep 2026 10 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Man Industries reported robust performance in Q1 FY27 with consolidated EBITDA reaching a record INR155 crores (up 92.6% YoY) and stand-alone PAT more than doubling YoY, driven by optimized product and geographic mix. Management maintains an optimistic outlook underpinned by a structural multiyear demand cycle across MENA, GCC, and Southeast Asia, along with strategic capacity additions in Saudi Arabia (NPC acquisition, Dammam coating facility) and Jammu (stainless steel proj Evidence summary ready | |
| COCHINSHIP Cochin Shipyard Limited Industrials · Mid | Sep 2026 10 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Cochin Shipyard reported stable performance for Q1 FY27 with a turnover of INR 1,094.21 crores, PBT of INR 202.49 crores, and PAT of INR 151.45 crores. Management maintains a positive long-term growth outlook supported by a robust order book of INR 22,000 crores, expansion into ship repair and hybrid shipbuilding facilities, and strategic international partnerships despite execution dependencies and working capital pressures. Evidence summary ready | |
| KARAMTARA Karamtara Engineering Limited Industrials · Micro | Sept 2026 9 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | Karamtara Engineering Limited delivered a strong first quarterly performance as a listed company for Q1 FY27, reporting 72% YoY revenue growth to INR1,581 crores and 45% YoY PAT growth to INR87 crores, driven by robust renewable demand and international expansion. Evidence summary ready | |
| WABAG VA Tech Wabag Limited Infra · Micro | Sept 2026 7 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call Guidance maintained | VA Tech Wabag reported record FY 2025-26 performance with revenue of INR 3,944 Crores, EBITDA of INR 524 Crores, and PAT of INR 371 Crores, supported by a robust order book exceeding INR 17,200 Crores and a net cash positive position for the sixth consecutive year. Evidence summary ready | |
| GRANULES Granules India Limited Pharma · Large | Sept 2026 6 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Granules India Limited reported returning to growth in FY26 after three years of flat performance, backed by a strong net cash position following preferential warrants in September 2026. The company is executing a strategic transformation focusing on four growth engines (controlled substances, complex generics/early market opportunities, oncology, and peptide CDMO) while funding a 2,000 crore organic capex plan over the next 3 to 4 years. Evidence summary ready | |
| STEAMHOUSE Steamhouse India Limited Chemicals · Micro | Sept 2026 6 Oct 2026 Preliminary brief | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | Steamhouse India Limited delivered robust operational performance for Q1 FY27, driven by strong growth in steam volumes and operating leverage, while completing its strategic exit from low-margin coal trading effective April 1, 2026. Evidence summary ready |